"We will continue to work closely with the authorities toward approval in the EU." Welireg generated $139 million in sales during 2024’s third quarter and is the only approved HIF-2α inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback